0 CHECKOUT

PRODUCT FILTERS

REGION

44
33
29
27
18

COUNTRY

13
11
7
6
3

PRICE

41
80
121
171

PUBLISHED

2
14
58
171

PRODUCT TYPE

164
2
1
1
1
1
1

Generic Drugs Market Research Reports

The global generics market is fast growing, driven by demand for cost-effective medicines and new availability of high value products. By now there are 17 generic companies with revenues in excess of US$1 billion, while there were only 12 in 2008/09.

The reports, books, and subscriptions listed under Research and Markets’ Generic Drugs category cover every aspect of this industry, such as market trends, forecasts, drivers and restraints, etc. They will allow you to identify business opportunities and assess the strategies of the major players. You can also investigate the latest international and national patent opportunities across a vast number of INNs (international non-proprietary names), taking into account key concerns such as expiry dates, national regulations, etc.

Key players featured in our publications includes Teva Pharmaceutical, Mylan, Sandoz, Watson Pharmaceuticals, Greenstone, Par Pharma, Hospira, Apotex, Mallinckrodt, Dr. Reddy's, and more. Show Less
Read more

New Generics - Guide to the products and markets 2013 Vol 2

Your essential guide to generic agrochemical products and markets is fully updated for 2013. This is the second report of a three-volume set and a complete update of the best-selling 2007 editions. Key...

Published:  March 2013
Price:  From

Opioids Market to 2018 - Increasing Concentration of Abuse-Resistant Branded Generics Alter Competitive Dynamics in this Flat Market

Leading business intelligence provider GBI Research has released its latest research report, entitled “Opioids Market to 2018 - Increasing Concentration of Abuse-Resistant Branded Generics Alter Competitive...

Published:  January 2013
Price:  From

The Top 60 European Manufacturers Of Generic Pharmaceuticals

"The Top 60 European Manufacturers Of Generic Pharmaceuticals" is perfect for those companies who want to identify and make contact with the leading European manufacturers of generic pharmaceuticals...

Published:  October 2012
Price: 

Brazilian Generic Industry Guide

The Brazilian pharma market is growing rapidly into one of the largest pharma markets in the world Unbranded and branded generics are among the fastest growing segments within this market For 2012,...

Published:  September 2012
Price: 

Active Pharmaceutical Ingredients (API) Market in the Americas to 2017 - Shift Towards Generics and Biosimilars as South and Central America Emerges as a Key Growth Region

Active Pharmaceutical Ingredients (API) Market in the Americas to 2017 - Shift Towards Generics and Biosimilars as South and Central America Emerges as a Key Growth Region Summary GBI Research's report,...

Published:  August 2012
Price:  From

Profound Research and Investment Prospect of China's Generic Drug Market, 2012-2016

By now, there are more than 10,000 kinds of generic drugs in China, accounting for the vast majority of drug consumption market There are more and more drug varieties and the quality becomes better...

Published:  August 2012
Price:  From

Active Pharmaceutical Ingredients (API) Market in Europe to 2017 - Pricing and Reimbursement Initiatives Supporting Generic Drug Growth, with CMOs Expected to Account for Majority of the Manufacturing Activity

GBI Research’s report, “Active Pharmaceutical Ingredients (API) Market in Europe to 2017 - Pricing and Reimbursement Initiatives Supporting Generic Drug Growth, with CMOs Expected to Account for Majority...

Published:  July 2012
Price:  From

Generics in the Antivirals Market to 2018 - Launch of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will Drive Volume Growth

Generics in the Antivirals Market to 2018 - Launch of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will Drive Volume Growth Summary GBI Research in its present report ”Generics...

Published:  June 2012
Price:  From

Bone Metabolism Therapeutics Market to 2018 - Hyperparathyroidism Sector to Decline in the Absence of New Product Launches and Increased Generic Erosion for Zemplar, Hectorol and Sensipar

Bone Metabolism Therapeutics Market to 2018 - Hyperparathyroidism Sector to Decline in the Absence of New Product Launches and Increased Generic Erosion for Zemplar, Hectorol and Sensipar Summary GBI...

Published:  June 2012
Price:  From

Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market Exclusivities and Impending Patent Expirations of Plavix to Drive Generic Substitution

GBI Research, the leading business intelligence provider, has released its latest research “Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market Exclusivities and Impending Patent...

Published:  May 2012
Price:  From

Orphan Disease Therapeutic Disorders to 2018 - Emerging utics in GenAgents in Cystic Fibrosis Offer Strong Opportunities for Investment and Licensing Activity

GBI Research, the leading business intelligence provider, has released its latest research, “Orphan Disease Therapeutics in Genetic Disorders to 2018 - Emerging Agents in Cystic Fibrosis Offer Strong...

Published:  May 2012
Price:  From

Antivirals Market to 2017 - Increased Uptake of High Priced Combination Drugs will Offset the Impact of Generics in the HIV Therapeutics Market

GBI Research, the leading business intelligence provider, has released its latest research “Antivirals Market to 2017 - Increased Uptake of High Priced Combination Drugs will Offset the Impact of Generics...

Published:  April 2012
Price:  From

Pricing and Reimbursement in Generics - European Austerity Measures and Healthcare Cost Containment Puts Innovation-Driven Pharma Companies under Pressure

GBI Research, the leading business intelligence provider, has released its latest research “Pricing and Reimbursement in Generics - European Austerity Measures and Healthcare Cost Containment Puts Innovation-Driven...

Published:  April 2012
Price:  From

Growth Strategies for Supergenerics Organizations - Opportunities in Addressing Unmet Medical Needs and Providing Cost-Effective Solutions for Product Development in Emerging Markets

GBI Research, a leading business intelligence provider, has released its latest research “Growth Strategies for Supergenerics Organizations - Opportunities in Addressing Unmet Medical Needs and Providing...

Published:  April 2012
Price:  From

Branded Generics in South East Asia: Current and Future Opportunities

With its fast-growing, young population and projected pharmaceutical sales in excess of $20 billion in 2014, countries in the Association of South East Asian Nations (ASEAN) represent a great opportunity...

Published:  April 2012
Price:  From

Herpes Market to 2018 - Genericization Compels Competitors Seeking Differentiation to Adopt Novel Drug Delivery Technologies

GBI Research's report ""Herpes Market to 2018 - Genericization Compels Competitors Seeking Differentiation to Adopt Novel Drug Delivery Technologies"" finds that the global herpes market is an attractive...

Published:  April 2012
Price:  From

Assessment of the Japan Generics Industry

While Japan is the second largest pharma market globally, it has a very low penetration rate of generic drugs The country’s government has set an ambitious goal to enhance the generics penetration to...

Published:  March 2012
Price:  From

Top Ten ANDA / PARA-IV / API Opportunities To Be Targeted By Generic or Active Pharmaceutical Ingredient Companies

Top Ten ANDA / PARA-IV / API Opportunities To Be Targeted By Generic or Active Pharmaceutical Ingredient Companies Product Selection is one of the most crucial aspects of growth strategy for a generic...

Published:  March 2012
Price:  From

Japan Generics Market Analysis

Japan is the world’s second largest pharmaceutical markets in the world, but due to public perception, the share of generic drugs has remained low in it However, worried over rising healthcare expenses...

Published:  February 2012
Price:  From

Pricing and Reimbursement in the US - Non-LIS Beneficiaries Not Covered by Medicare Coverage Gap to Gain from Reduction in Out-of-Pocket Expenditure for Generic Drugs

GBI Research, the leading business intelligence provider, has released its latest research “Pricing and Reimbursement in the US - Non-LIS Beneficiaries Not Covered by Medicare Coverage Gap to Gain from...

Published:  February 2012
Price:  From
Loading Indicator

Our Clients